126P Evaluation of myeloid targeting agents, PY159 and PY314, in two dose expansion phase Ib trials in platinum-resistant ovarian cancer
| Autor: | Yeku, O.O., Barve, M., Tan, W.W., Wang, J.S., Patnaik, A., Lorusso, P., Naqash, A-R., Dowlati, A., Fu, S., Gordon, M., Hubbard, J., Kummar, S., Kyriakopoulos, C.E., Schenk, E., Deegan, D., Liang, L., Li, Y., Reyno, L., Chamberlain, M., Winer, I. |
|---|---|
| Zdroj: | In Immuno-Oncology and Technology December 2023 20 Supplement |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|